Search Within

James J Hsieh

Formats
  1. Journal Article (69)
  2. Meeting Abstract (53)
  3. Book Section (2)
  4. Conference Paper (1)
Groups
  1. Human Oncology and Pathogenesis Program (91)
  2. Department of Medicine (74)
  3. Solid Tumor Oncology Division (73)
  4. Surgery (73)
  5. Urology (72)
  6. Department of Pathology and Laboratory Medicine (71)

More Groups

People
  1. Abraham Hakimi (72)
  2. Robert Motzer (58)
  3. Martin Voss (54)
  4. Paul Russo (37)
  5. Yingbei Chen (37)
  6. Victor Reuter (35)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (3)
  5. 2017 (15)
  6. 2016 (31)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. BJU International (10)
  3. Cancer Cell (5)
  4. Modern Pathology (5)
  5. Cancer Research (4)
  6. European Urology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. Nature Publishing Group (12)
  3. Wiley Blackwell (12)
  4. Cell Press (10)
  5. Elsevier Inc. (10)
  6. American Association for Cancer Research (8)

More Publishers

Results (125)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer
    Journal Article

    Nixon, B. G.; Kuo, F.; Ji, L.; Liu, M.; Capistrano, K.; Do, M.; Franklin, R. A.; Wu, X.; Kansler, E. R.; Srivastava, R. M.; more...
    Immunity (2022)

    Fulltext@MSK | Save
  • Integrated-omics of MRI-visible and -invisible prostate cancer identifies molecular correlations with clinical outcome
    Meeting Abstract

    Kim, E.; Miheecheva, N.; Ramachandran, A.; Lyu, Y.; Galkin, I.; Svekolkin, V.; Postovalova, E.; Bagaev, A.; Nomie, K.; Ogloblina, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma
    Journal Article

    Casuscelli, J.; Becerra, M. F.; Manley, B. J.; Zabor, E. C.; Reznik, E.; Redzematovic, A.; Arcila, M. E.; Tennenbaum, D. M.; Ghanaat, M.; Kashan, M.; more...
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
    Journal Article

    Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save
  • Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC)
    Meeting Abstract

    Voss, M. H.; Novik, J. B.; Hellmann, M. D.; Ball, M.; Hakimi, A. A.; Miao, D.; Margolis, C.; Horak, C.; Wind-Rotolo, M.; De Velasco, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma
    Journal Article

    Gatto, F.; Blum, K. A.; Hosseini, S. S.; Ghanaat, M.; Kashan, M.; Maccari, F.; Galeotti, F.; Hsieh, J. J.; Volpi, N.; Hakimi, A. A.; more...
    European Urology Oncology (2018)

    Fulltext@MSK | Save
  • In vivo PET assay of tumor glutamine flux and metabolism: In-human trial of (18)F-(2S,4R)-4-fluoroglutamine
    Journal Article

    Dunphy, M. P. S.; Harding, J. J.; Venneti, S.; Zhang, H.; Burnazi, E. M.; Bromberg, J.; Omuro, A. M.; Hsieh, J. J.; Mellinghoff, I. K.; Staton, K.; more...
    Radiology (2018)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma
    Journal Article

    Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
    Kidney Cancer (2017)

    Fulltext@MSK | Save
  • Integrated biomarker analysis for 412 renal cell cancer (RCC) patients (pts) treated on the phase 3 COMPARZ trial: Correlating common mutation events in PBRM1 and BAP1 with angiogenesis expression signatures and outcomes on tyrosine kinase inhibitor (TKI) therapy
    Meeting Abstract

    Voss, M. H.; Kuo, F.; Chen, D.; Marker, M.; Patel, P.; Redzematovic, A.; Riaz, N.; Chan, T. A.; Choueiri, T. K.; Hsieh, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples
    Journal Article

    Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
    European Urology Focus (2017)

    Fulltext@MSK | Save